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Abstract 
 
Persistent digital hyperthermia, presumably due to vasodilation, has been shown to 
occur during the developmental and acute stages of insulin-induced laminitis. This 
study sought to determine if persistent digital hyperthermia is the principle pathogenic 
mechanism responsible for the disease. A potent vasodilator, ATP-MgCl2 was infused 
continuously into the left forefoot of six Standardbred racehorses for 48 h via an intra-
osseous infusion into the distal phalanx (0.11mg/kg/min), to promote persistent digital 
hyperthermia. The right forefoot was infused with saline solution and acted as an 
internal control. Clinical signs of lameness at the walk were not detected at 0 h, 24 h 
or 48 h. Mean ± se hoof wall temperature of the left fore (29.4 ± 0.25 ºC) was higher 
(P < 0.05) than the right (27.5 ± 0.38 ºC). Serum insulin (15.0 ± 2.89 µIU/mL) and 
blood glucose (5.4 ± 0.22 mM) concentrations remained unchanged during the 
experiment. Histopathological evidence of laminitis was not detected in any horse. 
The results show that digital vasodilation up to 30°C for a period of 48 h, does not 
cause laminitis in the absence of hyperinsulinaemia. Thus, although digital 
hyperthermia may play a role in the pathogenesis of laminitis, it is not the sole 
mechanism.  
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Introduction 
 
Equine laminitis is a serious foot disease of horses (USDA, 2000) characterised by 
lameness, increased digital pulses and palpably warm hooves. While it is assumed that 
an increase in perfusion occurs in the acute phase of laminitis, there has been 
considerable debate on the role of the vasculature during the developmental phase. 
Some researchers have suggested that a decrease in blood flow to the foot may occur 
(Adair et al., 2000), or blood may be shunted away from the digital microcirculation 
through dilated arteriovenous anastomoses (Robinson, 1990) during laminitis 
development, resulting in lamellar ischaemia. On the other hand, an increase in hoof 
temperature, and presumably blood flow to the foot, has been recorded during the 
developmental phase of both carbohydrate- (Pollitt and Davies, 1998) and insulin-
induced (de Laat et al., 2010) laminitis. Insulin achieves vasodilation through its 
interaction with the vascular endothelium and the release of nitric oxide (Baron, 1996) 
which is the potential mechanism for the digital vasodilation seen during 
hyperinsulinaemic laminitis in horses (de Laat et al., 2010). 
 
The developmental phase of naturally-occurring laminitis often goes unrecognised 
and as a result, the opportunity to monitor blood flow during this pre-clinical phase is 
missed. In particular, endocrinopathic laminitis offers little opportunity to study its 
developmental phase as the precise time of onset in at-risk individuals can be difficult 
to predict (Geor, 2008; Menzies-Gow et al., 2010). Experimentally-induced 
hyperinsulinaemic laminitis is associated with persistently elevated hoof wall 
temperature during the developmental phase that is consistently higher, and less 
variable than the hoof temperature recorded in control animals (de Laat et al., 2010). 
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The increased hoof temperature recorded in this study was presumably a reflection of 
increased digital perfusion and was attributed to the vasodilatory effects of insulin. 
The purpose of the current study was to investigate the role of persistent digital 
vasodilation in the pathogenesis of insulin-induced laminitis. The aim of the study 
was to induce persistent digital vasodilation over 48 h with ATP-MgCl2, in order to 
determine whether digital hyperthermia per se is sufficient to cause laminitis in the 
absence of hyperinsulinaemia. 
 
Adenosine 5’ triphosphate (ATP) is a powerful vasodilator and acts via purinoceptors 
located on vascular endothelial cells, to achieve its effects on vascular tone 
(Burnstock and Kennedy, 1986). A combination of ATP and magnesium chloride 
(MgCl2) has been investigated as a potential therapy to improve perfusion following 
sepsis (Chaudry et al., 1980), shock (Chaudry et al., 1976) and ischaemia (Paskitti and 
Reid, 2002). ATP-MgCl2 has been demonstrated to be safe for intravenous use in 
horses and has successfully increased blood flow in a dose-dependent manner up to a 
maximal safe infusion rate (Tetens et al., 1999).  ATP-MgCl2 was selected for use in 
the current study as it was likely to increase digital blood flow following intraosseous 
infusion into the distal phalanx. Thus, a secondary aim of the study was to determine 
the suitability of ATP-MgCl2 as a vasodilatory agent following intraosseous perfusion 
in the horse. 
 
Intraosseous infusion techniques have been used successfully in the metacarpal (Keys 
et al., 2006; Mattson et al., 2004) and phalangeal (Nourian et al., 2010; Rubio-
Martinez et al., 2005) bones of horses. There are numerous medullary sinuses in the 
body of the distal phalanx of the horse traversed by abundant blood vessels (Nourian, 
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2009). These blood vessels connect directly to the lamellar vasculature via numerous 
anastomoses (Nourian, 2009). Intraosseous infusion of the distal phalanx (IOIDP) 
provides access to the medullary circulation and thus a direct route for administration 
of substances into the terminal digital circulation and lamellar microenvironment 
(Nourian et al., 2010). In the current study, continuous intraosseous infusion of the 
distal phalanx was preferred over intra-arterial or intravenous catheterisation due to 
the extended nature of the experiment (48 h) and the perceived likelihood of 
equipment failure during prolonged vascular catheterisation of both forelimbs in a 
standing, conscious horse. Furthermore, successful infusion of the distal phalanx 
occurs without the need for a tourniquet (Nourian et al., 2010). The hypothesis of this 
study was that prolonged infusion of ATP-MgCl2 into one forelimb would result in 
lamellar vasodilation and persistent hyperthermia, and this would not result in 
development of laminitis in the treated limb.  
 
Materials and Methods 
 
Subjects 
 
Six clinically healthy (mean bodyweight: 430 ± 17 kg), male Standardbred racehorses 
in moderate body condition (body condition score: 4-5/9; (Henneke et al., 1983) were 
randomly selected for use in this study. All of the horses (mean age: 5.2 ± 0.73 years) 
were unremarkable on physical examination with no evidence of endocrine disease or 
any phenotypic indicators of insulin resistance (cresty neck score: 0/5; (Carter et al., 
2009a). All horses were walked and trotted out for lameness while being videotaped 
before, during and after the experiment, and any horse that was unsound at 
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commencement was eliminated from the experiment. Plain, lateral radiographs were 
taken, and visual inspection of both front feet was performed, before the study to 
identify horses with pre-existing foot pathology. The horses were then paired 
randomly and the experiment was conducted in a purpose-built, climate-controlled 
facility as three replicates over a ten-day period during sub-tropical mid-winter. The 
horses were accommodated in the facility for 48 h prior to the study to allow 
environmental acclimatisation. Appetite, demeanour, heart and respiratory rate and 
rectal temperature were monitored every 4 h throughout the experimental period. 
Urine analysis was performed prior to, and at the end of the study to assess urine 
specific gravity and to look for the presence of glucose, ketones, protein and red and 
white blood cells. Medium quality lucerne chaff, lucerne hay and water were available 
to the horses ad libitum for the 48 h preceding, and throughout the experiment.  
 
Blood sampling 
 
Blood samples (20 mL) were drawn at the beginning and end of the study from a 14 G 
intravenous, extended-use catheter (MilaCath, Mila) placed in the left jugular vein, to 
monitor haematologic (vacutainer containing EDTA; Greiner)  and biochemical (plain 
vacutainer; Greiner) variables as an indicator of general health status.   Haematologic 
parameters included haemoglobin, red and white cell count and cell morphology, 
packed cell volume, platelet count and thrombocytes, while biochemical analysis 
included electrolytes (sodium, potassium, chloride), aspartate transaminase, alkaline 
phosphatase, γ-glutamyltransferase, bicarbonate, calcium, anion gap, magnesium, 
phosphorus, protein (total, albumin, globulin), urea , creatinine, cholesterol, 
triglycerides, creatinine kinase and total bilirubin. Blood samples (5 ml) were also 
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drawn to measure serum insulin and blood glucose concentrations at 6 h intervals 
throughout the study. Blood glucose was measured immediately using a handheld 
glucometer (Accucheck Go, Roche) previously calibrated against the hexokinase 
method for equine blood by the authors (ρc = 0.96). Serum was obtained after 
allowing the blood sample to clot for 30 min and centrifuging it at 3000 g for 10 min. 
Aliquots of serum (1 mL) were stored at -80ºC until analysed. Serum insulin 
concentration was determined for each sample using a radioimmunoassay (Coat-a-
count, Siemens) previously validated for use in horses (McGowan et al., 2008).  
 
Formulation and administration of ATP-MgCl2 
 
The ATP-MgCl2 solution was prepared using adenosine 5’-triphosphate disodium salt 
(A3377, Sigma) and magnesium chloride hexahydrate (M2670, Sigma) according to 
previous descriptions (Chaudry, 1982). Adenosine 5’ triphosphate (0.605 g; 1000 
µmol) of was dissolved in 2.5 mL of cold, deionised water and the pH adjusted to 7.0 
using 1.0 M sodium hydroxide (NaOH). The final pH of the solution was increased to 
7.4 with 0.1M NaOH. The volume was then made up to 5 mL with cold, deionised 
water and kept on ice. Magnesium chloride (0.2033 g; 1000 µmol) was dissolved in 5 
mL of cold, deionised water, mixed with the ATP solution and sterilised with a 0.22 
µm filter (Millipore). This solution was then kept on ice until use or stored at -20ºC in 
10 mL aliquots for up to 2 weeks. 
 
The safe maximal intravenous infusion rate of ATP-MgCl2 in horses has been shown 
to be 0.3 mg/kg/min, however a dose rate of 0.2 mg/kg/min was demonstrated as 
sufficient to achieve peripheral vasodilation without accompanying hypotension 
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(Tetens et al., 1999). For the current study, a dose rate of 0.2 mg/kg/min was selected 
for the intra-osseous infusion and was calculated based on the weight of the hoof 
rather than the horse. The average weight (1.61 ± 0.05 kg) of the distal limb of a 
Standardbred horse was calculated by weighing fresh cadaver limbs (n = 12) obtained 
from a local abattoir that were disarticulated at the fetlock. ATP-MgCl2 (7.66 mL; 
463.68 mg) of solution was mixed with 22.34 mL of cold 0.9% saline (Baxter) and 
infused into the left fore foot over 24 h with a 30 mL, re-usable, spring-driven syringe 
pump (Springfusor, Go Medical) through flow control tubing (Springfusor, Go 
Medical), to deliver a constant intra-osseous infusion rate of 0.02 ml/min. The 
springfusor was reloaded with fresh solution and sterile flow control tubing was 
attached for the second 24 h period. The right fore foot was infused with 30 mL of 
cold 0.9% normal saline over each 24 h period using an identical Springfusor. 
 
Intra-osseous infusion technique 
 
The horses were administered 0.04 mg/kg bwt of the sedative romifidine 
hydrochloride (Sedivet, Boehringer Ingleheim) IV prior to bilateral, abaxial, 
perineural, digital nerve blockade using a short-acting local anaesthetic (2% 
lignocaine, Troy). An insertion site was marked on the dorsal surface of the front 
hooves, 25 mm below the hairline and 30 mm lateral to the midline, prior to the 
hooves being cleaned with a wire brush and disinfected with chlorhexidine. A circular 
area of 10 mm radius around the insertion point was then cauterised to a depth of 2 
mm using a custom-made iron, heated to red-hot in a gas forge. An intra-osseous 
needle (EZ IO AD 25mm, Vidacare) was inserted at right angles to the hoof wall at 
the midpoint of the sterilised area using a specialised drill (EZ IO Power Driver, 
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Vidacare). The needle was passed through the hoof wall and lamellar region into the 
dorsal cortex of the distal phalanx (Fig 1). Once resistance to drilling decreased, 
indicating penetration of the dorsal cortex, the drill and needle stylet were removed 
and a pre-loaded syringe of heparinised saline with 15 cm extension tubing (EZ 
Connect, Vidacare) was attached to the luer-lock hub of the intra-osseous needle, and 
the system flushed. Once patent, the Springfusor was attached to the needle via the 
flow control tubing, and the infusion commenced. The needle was protected with 
Elastoplast (Beiersdorf) and the Springfusor was secured in a custom-designed 
neoprene boot (Fig 2). Further local anaesthetic nerve blockade was not required. The 
horses were fitted with equine nappies (Equisan) to avoid urine or faecal 
contamination of the intra-osseous needle site. 
 
Hoof wall surface and ambient temperature 
 
A surface thermistor (TinyTag, Gemini) was placed on the midline of the dorsal 
aspect of the hoof wall, 25 mm below the hairline and 30 mm medial to the midline, 
on both front feet of each horse (Fig 2). Hoof wall surface temperature (HWST) was 
measured separately for both front feet every 5 min throughout the experimental 
period by a data logger connected to the thermistor. Ambient temperature was 
measured every 5 min by an identical thermistor and data logger placed within 1 m of 
the horse. 
  
Lamellar histopathology 
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At the conclusion of the experiment the horses were euthanased and samples of 
lamellar tissue were immediately obtained from the dorsal mid-section of both front 
feet. The forefeet were disarticulated at the metacarpo-phalangeal joint, sectioned 
with a band saw and then dissected to obtain 5 mm x 5 mm samples of lamellar tissue. 
The tissue was placed in 10% neutral buffered formalin for 24 h before being 
processed for histology by routine methods. The sections were stained with 
haematoxylin and eosin (H & E) and periodic acid Schiff (PAS). Samples were 
randomised then examined via light microscopy (Olympus BX-50) and classified as 
laminitis positive or negative by one author (C.C.P.) who was blinded to the origin of 
the samples. 
 
Ethical considerations and statistical analysis 
 
The experimental protocol was approved by the animal ethics committee of The 
University of Queensland (SVS/108/09/RIRDC) which ensures compliance with the 
Animal Welfare Act of Queensland (2001) and the Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes (7th edition 2004). All horses were 
continuously monitored throughout the experimental period by a registered 
veterinarian. Repeated measures analysis of variance (ANOVA) was used to measure 
the change in insulin, glucose, heart and respiratory rates and body temperature for 
the duration of the experiment. HWST data over time was also analysed with a 
repeated measures ANOVA, with ambient temperature included as a covariate in the 
analysis. Overall HWST was compared between the treated and control limbs, or 
between basal and infusion time-points, using an unpaired and paired t-test 
respectively. Agreement between the two methods for assessing blood glucose was 
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analysed using Lin’s concordance co-efficient (ρc). All data are presented as mean ± 
se and statistical significance was accepted at P < 0.05. Statistical analyses were 
performed using the R project for statistical computing, version 7.2.7. 
 
Results 
 
Subjects and clinical outcomes 
 
The intraosseous infusion of the ATP-MgCl2 solution was reasonably well tolerated in 
all horses. Four of the horses showed mild, periodic discomfort associated with the 
infusion of ATP-MgCl2 as evidenced by occasional pawing with the left forelimb. 
This discomfort was usually seen after changing the springfusor at the 24 h time-point, 
but also occurred at a later time-point (40 h) in one horse. Discomfort was treated 
with a single, intravenous dose of flunixin meglumine (1.1 mg/kg), a non-steroidal 
anti-inflammatory drug (NSAID) at 24 h in three horses and at 40 h in a fourth horse, 
and effectively abolished pain within 15 min. None of the horses developed clinical 
signs of lameness and were sound at the walk at the 24 h (performed before all doses 
of NSAID were administered) and 48 h time-points. 
 
Appetite, heart rate (37.2 ± 1.97 beats per min), respiratory rate (12.0 ± 1.97 breaths 
per min) and rectal temperature (37.7 ± 0.22 ºC) did not change throughout the 
experiment. All of the horses remained clinically normal except for one horse that 
developed a mild, transient cough. Biochemistry, haematology and urinalysis test 
results were within accepted diagnostic laboratory reference ranges for the duration of 
the experiment for all horses (Olson et al., 1993). Serum insulin (15.0 ± 2.89 µIU/ml) 
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and blood glucose concentrations (5.4 ± 0.22 M) also remained stable, and within 
previously published reference ranges for basal values (Kronfeld, 2006; Pratt et al., 
2005; Treiber et al., 2005), in all horses throughout the experimental period (Fig 3). 
 
Due to the viscous nature and the cool temperature (to minimise ATP degradation) of 
the ATP-MgCl2 solution, and the cool temperature of the saline solution, the 
Springfusor system was unable to maintain the desired intra-osseous infusion rate of 
0.02 ml/min (optimal solution temperature is 25°C). Instead of 60 mL, the treated 
limbs received an average of 32.5 ± 2.4 ml while the control limbs received 38.3 ± 2 
ml, in the 48 h period. This resulted in an infusion rate of 0.01 mL/min in both the left 
and right fore. This reduced infusion rate meant that the final dose rate of ATP-MgCl2 
was 0.11 mg/kg/min. 
 
Hoof wall surface and ambient temperature 
 
Overall mean (± se) HWST of the foot treated with ATP-MgCl2 (left fore; 29.4 ± 0.25 
ºC) was higher (P < 0.05) than the foot treated with 0.9% saline (right fore; 27.5 ± 
0.38 ºC) during the 48 h treatment period. Basal HWST of the left fore (26.8 ± 0.31 
ºC) was similar to the right fore (26.3 ± 0.6 ºC) at the start of the experiment (Table 1). 
However, the temperature of the treated foot increased (P < 0.05) during the first 4 h 
of the experiment and remained significantly elevated above basal and control foot 
temperature, at every time-point during the remainder of the experiment (Fig 4). The 
HWST of the right forefoot (control) during the infusion period did not differ from the 
basal level at any time-point (Table 1). Ambient temperature remained constant (17.1 
± 0.31 ºC) throughout the experiment for all of the horses.  
 13 
 
Lamellar histopathology 
 
All sections from both front feet of all the horses were classified as normal (Fig 5a 
and b). Lamellar histology of all samples had the appearance of classic lamellar 
architecture in horses with normal foot health (Obel, 1948). The primary epidermal 
lamellae were uniform in length and interdigitated with primary dermal lamellae (Fig 
5). The secondary epidermal lamellae were uniform in length, symmetrically angled 
to the primary epidermal lamellar axis and had rounded tips with intact basement 
membrane (Fig 5). The epidermal basal cell nuclei were ovoid and either apically or 
centrally located in the cell. Mitotic figures were rare and apoptotic cells infrequent. 
Dermal vessels were prominent in treated foot sections (Fig 5). 
 
Discussion  
 
Hoof wall surface temperature (HWST) is assumed to be a reliable indicator of 
underlying perfusion if measured in environmentally-acclimatized horses under 
conditions of constant, moderate ambient temperature and minimal mechanical 
activity (Hood et al., 2001), as was done in the current study. A previous study has 
shown that experimentally-induced hyperinsulinaemic laminitis was associated with 
increased HWST (de Laat et al., 2010). Elevated HWST has also been recorded in 
ponies that had previously suffered from naturally-occurring cases of pasture-
associated laminitis, when compared to ponies that had never been laminitic (Carter et 
al., 2009b), although ambient temperature was not controlled for. The HSWT of the 
treated feet of horses in this current study slightly exceeded the HWST recorded in 
 14 
laminitic horses subject to prolonged hyperinsulinaemia previously (de Laat et al., 
2010). Thus, the failure of the horses to develop clinical and histopathological 
laminitis within 48 h, while the horses with prolonged hyperinsulinaemia did, 
suggests that the pathogenesis of insulin-induced laminitis is not entirely due to a 
dilatory vascular mechanism.  
 
The hyperinsulinaemic, laminitic horses also showed minimal variation in HWST 
over the 48 h treatment period when compared to the variable HWST of their controls. 
This HWST variability in the control group was presumed to reflect periods of digital 
vasodilation and vasoconstriction and may have been important for maintaining 
normal lamellar health. However, in the current study, the untreated (control) limb 
showed only marginally more variability in HWST than the treated limb. It is likely 
that using a contralateral limb from the same horse as a control, limited the ability to 
compare HWST variability. However, as neither the untreated nor treated limb 
developed laminitis, the ability to regularly vasoconstrict the digit may not be 
important in preventing laminitis development in the absence of other factors 
(systemic inflammation or hyperinsulinaemia).  
 
Mean HWST of the control limbs in the current study also increased marginally above 
basal levels following commencement of the infusion, although this increase was not 
significant. This mild elevation in HWST was potentially caused by a local 
inflammatory response to the intraosseous needle resulting in an increase in blood 
flow. It is also possible that bandaging the feet may have marginally increased foot 
temperature through reduced atmospheric heat loss. Regardless, both the treated and 
control foot were treated in an identical fashion which should account for these 
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external factors. However, the IOIDP procedure and bandaging may have influenced 
the decrease in HWST variability seen in the control limbs in the current study when 
compared to HWST in control horses used in a previous study (de Laat et al., 2010). 
Another variable of this study was the administration of the NSAID, flunixin, to four 
of the horses for pain relief. Potentially, flunixin treatment may have altered the 
degree of digital perfusion by inhibiting inflammation and the attendant vasodilation, 
hence decreasing HWST in treated horses. However, systemic administration of the 
drug ensured that both the treated and control limbs were medicated and NSAID 
treatment did not appear to overtly affect the outcome of significantly increased 
HWST in the treated limb. 
 
While persistent vasodilation may play a role in the developmental phase of 
hyperinsulinaemic laminitis (de Laat et al., 2010) the results of the current study 
would suggest the involvement of other factors, such as insulin or glucose. Insulin is 
an important vasomediator (Baron, 1994) and its potent vasodilatory effect was 
probably responsible for the increased HWST seen in horses with insulin-induced 
laminitis (de Laat et al., 2010).  The current study endeavoured to determine whether 
vasodilation alone (in the absence of hyperinsulinaemia) was laminitogenic. While the 
current findings do not support this suggestion, they do not rule out the possibility that 
the vasodilatory effects of insulin are contributory to the development of insulin-
induced laminitis. 
 
Intra-osseous infusion of ATP-MgCl2 at the dose rate of 0.11 mg/kg/min significantly 
raised HWST, and, by implication, increased lamellar perfusion. The slow infusion 
rate (0.01ml/min) minimised volume overload of the tissues, thus minimising the 
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degree of foot pain. In four of the horses minor foot discomfort occurred in response 
to the ATP-MgCl2 infusion. This was assumed to be due to the cool temperature of 
the solution or an unpleasant, local sensation secondary to the action of ATP-MgCl2. 
Properties of the solution itself, such as osmolality, may have also been irritant to the 
tissues. However, lamellar histopathology indicated that no visible detrimental effect 
on the lamellar tissue occurred. Thus, ATP-MgCl2 would appear to be a safe and 
effective compound for inducing local digital vasodilation in the horse. The inclusion 
of a local anaesthetic drug, such as lignocaine, in the infusate may have helped to 
abolish foot pain and further studies to investigate this are required. Potential clinical 
applications of the findings of this study may include using ATP-MgCl2 for 
therapeutic management of ischaemic injuries to tissues within the equine digital 
environment. For example, if the pathogenesis of laminitis involves lamellar 
ischaemia-reperfusion injury then a local infusion of ATP-MgCl2 may provide 
therapeutic benefit. Furthermore, our results suggest that procedures resulting in 
persistent digital vasodilation for up to 48 h, such as prolonged nerve blocks, are 
unlikely to induce laminitis per se, via a vasodilatory mechanism. On the other hand 
prolonged low HWST and digital vasoconstriction appeared to confer protection in 
horses dosed with carbohydrate to induce laminitis (Pollitt and Davies, 1998). The 
pathogenesis of hyperinsulinaemic and carbohydrate-overload laminitis may be 
different and vasomodulatory therapies must be considered carefully and tailored 
individually if genuine benefit is to ensue. Indeed it has been suggested that 
indiscriminate vasodilation may promote the development of lamellar pathology in 
the carbohydrate-induction model (Pollitt and Davies, 1998). 
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Intra-osseous infusion of the distal phalanx is now confirmed as a feasible method for 
delivering substances to the lamellar circulation over 48 h. The technique does require 
specialised equipment and skills but these are not beyond the reach of equine 
veterinary hospitals or research facilities. Catheterisation of the digital artery has been 
used to deliver medications into the local circulation of the distal limb (Roberts, 1965) 
and IOIDP is now an additional viable option. While previous studies showed IOIDP 
effected drug delivery to the lamellar circulation for 6 h (Nourian et al., 2010), further 
work using other medications and for prolonged periods is required. In the current 
study no attempt was made to determine the concentration of ATP-MgCl2 in the 
lamellar tissue, as an increase in HWST was the aim of the study. Before IOIDP can 
be fully accepted in clinical practice, studies assessing the tissue penetration of 
infused substances over 48 h need to be performed.  
 
Conclusion 
 
Overall, the findings of the current study indicate that while persistent vasodilation 
throughout the developmental phase of insulin-induced laminitis may be involved in 
the pathogenesis of this condition, it is not the sole factor. Persistent digital 
hyperthermia up to 30°C in the distal forelimb of the horse secondary to a continuous 
intra-osseous infusion of ATP-MgCl2 at a dose rate of 0.11 mg/kg/min, does not 
appear to have any detrimental effects on the hoof or the horse, and does not result in 
laminitis. Prolonged intra-osseous infusion of the distal phalanx may prove to be a 
safe and effective method of drug delivery for the treatment or prevention of laminitis 
in the digit. 
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Tables 
 
Table 1: Mean ± se HWST was measured in the front feet of Standardbred racehorses 
(n = 6) treated with an intraosseous infusion into the distal phalanx of both forelimbs. 
The left fore (LF) was infused with a vasodilator, ATP-MgCl2, to induce digital 
hyperthermia while the right fore (RF) was infused with saline and acted as a control. 
HWST data from both forefeet is shown prior to commencement of the experiment (0 
h) and for each time-point during the 48 h infusion period. The HWST of the LF was 
higher (*, P < 0.05) than basal and control values throughout the infusion period. The 
RF HWST did not differ from basal levels during the experiment at any time-point.  
 
Time-point HWST °C LF - treated 
HWST °C 
RF - control 
0 h 26.9 ± 0.3 26.3 ± 0.6 
4 h 29.0 ± 0.15 * 27.0 ± 0.5 
8 h 29.1 ± 0.16 * 27.6 ± 0.47 
12 h 29.1 ± 0.21 * 27.1 ± 0.56 
16 h 29.2 ± 0.4 * 26.9 ± 0.45 
20 h 29.4 ± 0.4 * 27.3 ± 0.32 
24 h 29.5 ± 0.33 * 27.3 ± 0.41 
28 h 30.2 ± 0.28 * 27.8 ± 0.6 
32 h 29.5 ± 0.4 * 28.1 ± 0.5 
36 h 29.3 ± 0.44 * 27.6 ± 0.61 
40 h 29.1 ± 0.27 * 27.5 ± 0.39 
44 h 29.1 ± 0.26 * 27.7 ± 0.31 
48 h 29.5 ± 0.44 * 27.5 ± 0.37 
 
 22 
Figures 
 
 
 
Figure 1: Plain lateral radiograph of the left distal limb of one of the horses after 
placement of the intra-osseous (IO) needle (EZ IO AD 25 mm, Vidacare). The intra-
osseous needle has penetrated the hoof wall and lamellar region and the tip is inserted 
into the dorsal cortex of the distal phalanx (DP). 
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Figure 2: Both forelimbs of all horses were instrumented to allow intra-osseous 
infusion of a vasodilator, ATP-MgCl2, or 0.9% saline into the distal phalanx. The 
intra-osseous needle (EZ IO AD 25mm, Vidacare) was inserted through the dorsal 
surface of the hoof, at right angles to the hoof wall, 25 mm below the hairline and 30 
mm lateral to the midline (black arrows). A Springfusor (Go Medical) with pre-
calibrated flow control tubing (white arrows) was attached to the luer-lock hub of the 
intra-osseous needle. The needle was protected with Elastoplast (Beiersdorf) and the 
Springfusor was secured in a custom-designed neoprene boot. Surface thermistors 
(TinyTag, Gemini) were placed 25 mm below the hairline and 30 mm medial to the 
midline on the dorsal surface of both front feet and attached to data loggers worn by 
the horse that recorded the hoof surface temperature every minute (arrowheads). Blue 
equine nappies (Equisan) were worn by the horses to prevent waste contamination of 
the needles. 
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Figure 3: Mean ± se serum insulin (♦) concentration (µIU/mL) and blood glucose (○) 
concentration (mmol/L) of Standardbred horses (n = 6) treated with an intra-osseous 
infusion of a vasodilator, ATP-MgCl2 (LF) or normal saline (RF) into the distal 
phalanx for 48 h. Mean serum insulin and blood glucose concentrations did not 
change during the experiment. 
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Figure 4: Mean ± se hoof wall surface temperature (ºC) was measured in both front 
feet of Standardbred racehorses (n = 6). The left fore (●) was treated with a 
vasodilator (ATP-MgCl2) administered by an intra-osseous infusion over 48 h. The 
right fore (□) was infused intra-osseously with normal saline and acted as a control. 
Mean (± se) ambient temperature has been subtracted from the mean HWST for each 
horse. The treated limb was consistently warmer (P < 0.05) than the control limb at 
every time-point after 0 h. Neither foot developed any clinical or histopathological 
abnormalities. 
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Figure 5: Photomicrographs of hoof lamellar histology from the right (control; a) and 
left (ATP-MgCl2-treated; b) fore foot of Standardbred horses in transverse section. 
Hoof lamellar histology was normal in all sections examined. The primary epidermal 
lamellae (PEL) were uniform in length and interdigitated with primary dermal 
lamellae (PDL). The secondary epidermal lamellae (SEL) were symmetrically angled 
to the primary epidermal lamellar axis and had rounded tips with intact basement 
membrane (black arrow in a). The epidermal basal cell nuclei were ovoid (black 
arrowhead in a). The microvasculature in the dermis was subjectively noted to be 
dilated in the sections from the treated limb (black arrows in b) when compared with 
the untreated limb, in all horses. Stain – haematoxylin and eosin. Bar = 100 µm. 
